Seyfullah O. Arslan
Yildirim Beyazit, 06800, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Cryptotanshinone as a Multi-Target Natural Terpenoid with Bronchodilator Potential: Insights from Integrated In Vitro and In Silico Studies.
Journal: Molecules (Basel, Switzerland)
Published: April 15, 2026
Targeting Cannabinoid CB2 Receptors to Attenuate Airway Inflammation and Hyperresponsiveness in Allergic Asthma: Does the TRPV1 Receptor Play a Role?
Journal: Recent advances in inflammation & allergy drug discovery
Published: October 09, 2025
Thymoquinone ameliorates cognitive impairment and neuroinflammation in an amyloid-beta-induced rat model of Alzheimer's disease.
Journal: Brain research
Published: February 10, 2025
Highly Brominated Quinolines: Synthesis, Characterization, and Investigation of Anticancer Activities Supported by Molecular Dynamics.
Journal: Chemical biology & drug design
Published: August 16, 2024
The Role of Cannabinoid-1 Receptor Ligands in the Ovalbumin-Induced Mouse Model of Allergic Asthma: Is It Related to Transient Receptor Potential Vanilloid-1 Channels?
Journal: Cannabis and cannabinoid research
Published: April 24, 2024
Fenofibrate attenuates asthma features in an ovalbumin-induced mouse model via suppressing NF-κB binding activity.
Journal: Respiratory physiology & neurobiology
Published: February 24, 2023
Hydroxychloroquine induces endothelium-dependent and endothelium-independent relaxation of rat aorta.
Journal: Turkish journal of medical sciences
Published: April 30, 2021
Effects of cannabinoid receptor 2 synthetic agonist, AM1241, on bleomycin induced pulmonary fibrosis.
Journal: Biotechnic & histochemistry : official publication of the Biological Stain Commission
Published: December 16, 2020
Influence of Rosa damascena hydrosol on skin flora (contact culture) after hand-rubbing.
Journal: GMS hygiene and infection control
Published: September 25, 2020
CB2 Agonist (AM1241) Improving Effect on Ovalbumin-Induced Asthma in Rats.
Journal: Iranian journal of pharmaceutical research : IJPR
Published: September 14, 2020
Glabridin attenuates airway inflammation and hyperresponsiveness in a mice model of ovalbumin-induced asthma.
Journal: Pulmonary pharmacology & therapeutics
Published: April 01, 2020
Glabridin Alleviates Inflammation and Nociception in Rodents by Activating BKCa Channels and Reducing NO Levels.
Journal: Biological & pharmaceutical bulletin
Published: March 10, 2020
Last Updated: 09/26/2026